Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Arnault JP, Mateus C, Escudier B, Tomasic G, Wechsler J, Hollville E, Soria JC, Malka D, Sarasin A, Larcher M, André J, Kamsu-Kom N, Boussemart L, Lacroix L, Spatz A, Eggermont AM, Druillennec S, Vagner S, Eychène A, Dumaz N, Robert C. Arnault JP, et al. Among authors: wechsler j. Clin Cancer Res. 2012 Jan 1;18(1):263-72. doi: 10.1158/1078-0432.CCR-11-1344. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096025
Cutaneous side-effects of kinase inhibitors and blocking antibodies.
Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, Wechsler J, Lhomme C, Escudier B, Boige V, Armand JP, Le Chevalier T. Robert C, et al. Among authors: wechsler j. Lancet Oncol. 2005 Jul;6(7):491-500. doi: 10.1016/S1470-2045(05)70243-6. Lancet Oncol. 2005. PMID: 15992698 Review.
[Cutaneous side effects of sorafenib and sunitinib].
Autier J, Mateus C, Wechsler J, Spatz A, Robert C. Autier J, et al. Among authors: wechsler j. Ann Dermatol Venereol. 2008 Feb;135(2):148-53; quiz 147, 154. doi: 10.1016/j.annder.2007.12.006. Epub 2008 Feb 13. Ann Dermatol Venereol. 2008. PMID: 18342102 Review. French. No abstract available.
Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
Arnault JP, Wechsler J, Escudier B, Spatz A, Tomasic G, Sibaud V, Aractingi S, Grange JD, Poirier-Colame V, Malka D, Soria JC, Mateus C, Robert C. Arnault JP, et al. Among authors: wechsler j. J Clin Oncol. 2009 Aug 10;27(23):e59-61. doi: 10.1200/JCO.2009.23.4823. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597016 No abstract available.
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
Giacchero D, Ramacciotti C, Arnault JP, Brassard M, Baudin E, Maksimovic L, Mateus C, Tomasic G, Wechsler J, Schlumberger M, Robert C. Giacchero D, et al. Among authors: wechsler j. Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192. Arch Dermatol. 2012. PMID: 23247489 Clinical Trial. No abstract available.
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T. Grange F, et al. Among authors: wechsler j. Arch Dermatol. 2007 Sep;143(9):1144-50. doi: 10.1001/archderm.143.9.1144. Arch Dermatol. 2007. PMID: 17875875
Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects.
Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C, Prade M. Spatz A, et al. Among authors: wechsler j. Int J Cancer. 1996 Nov 4;68(3):317-24. doi: 10.1002/(SICI)1097-0215(19961104)68:3<317::AID-IJC9>3.0.CO;2-4. Int J Cancer. 1996. PMID: 8903473 Free article. Clinical Trial.
597 results